Related Experiment Videos
Hypercoagulability in otologic patients
S Gold1, D B Kamerer, B E Hirsch
1Department of Otolaryngology, University of Pittsburgh, School of Medicine, PA 15213.
Insights
Hypercoagulable states can complicate otologic disorders, leading to serious outcomes. Early diagnosis and hematologic consultation are crucial for managing these thromboembolic events in otolaryngology patients.
Area of Science:
- Otolaryngology
- Hematology
- Thrombosis
Background:
- Hypercoagulability can present with various otologic disorders.
- Awareness among otolaryngologists is key for timely diagnosis and management.
- Expert hematologic consultation is recommended for complex cases.
Observation:
- Three patients with otologic issues experienced hypercoagulability complications.
- Cases included dural venous sinus thrombosis, glomus jugulare tumor, and sudden sensorineural hearing loss.
- Patients were evaluated and treated in collaboration with hematology services.
Findings:
- One patient had inherited hypercoagulopathy; two had acquired forms.
- Two patients were stabilized with lifelong anticoagulation.
- One patient succumbed to complications, highlighting the severity of acquired hypercoagulable states.
Implications:
- Otolaryngologists must recognize and investigate thromboembolic events.
- Accurate diagnosis and characterization of hypercoagulable states impact treatment.
- Proactive management can improve patient outcomes in otologic hypercoagulability.
Introduction:
Three patients with otologic disorders developed complications related to hypercoagulability. This report was prepared to increase the awareness among otolaryngologists of the diagnosis and management of hypercoagulable states, and to encourage expert consultation when indicated.
Materials And Methods:
One patient with dural venous sinus thrombosis complicating an otitis media, one patient with a large glomus jugulare tumor, and one patient with a sudden sensorineural hearing loss were treated by the otolaryngology service. Suspicious thromboembolic events were evaluated by the hematology service, and appropriate anticoagulative therapy was recommended.
Results:
One patient with an inherited hypercoagulopathy and two patients with acquired hypercoagulopathies were treated for otologic problems. Two of the patients were stabilized and discharged on life-long anticoagulation therapy. The third patient, in spite of intensive medical and surgical support, eventually succumbed to complications to which an acquired hypercoagulable state made a significant contribution. Expert consultants made the hematologic diagnoses and treatment recommendations.
Conclusion:
Otolaryngologists should be aware that hypercoagulable states may now be more accurately diagnosed and characterized, and that thorough investigation of thromboembolic events may affect treatment decisions.